AlixaRx Receives $100M in Capital from Fillmore Capital Partners

AlixaRx, a Dallas-based provider of advanced pharmacy services in post-acute health care facilities, received $100m in capital from Fillmore Capital Partners.

A spin-off of Drumm Corp., the company leverages technology to deliver medication therapy management. AlixaRx operates full-service pharmacies staffed with clinical pharmacists and pharmacy technicians who use automated dispensing technology, electronic medication cabinets, and clinical software.

The company intends to expand into other health care settings outside of the post-acute sector.



Join the discussion